BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 25281978)

  • 1. Validation of simplified dosimetry approaches in ⁸⁹Zr-PET/CT: the use of manual versus semi-automatic delineation methods to estimate organ absorbed doses.
    Makris NE; van Velden FH; Huisman MC; Menke CW; Lammertsma AA; Boellaard R
    Med Phys; 2014 Oct; 41(10):102503. PubMed ID: 25281978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET/CT-derived whole-body and bone marrow dosimetry of 89Zr-cetuximab.
    Makris NE; Boellaard R; van Lingen A; Lammertsma AA; van Dongen GA; Verheul HM; Menke CW; Huisman MC
    J Nucl Med; 2015 Feb; 56(2):249-54. PubMed ID: 25613538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation dosimetry of 89Zr-labeled chimeric monoclonal antibody U36 as used for immuno-PET in head and neck cancer patients.
    Börjesson PK; Jauw YW; de Bree R; Roos JC; Castelijns JA; Leemans CR; van Dongen GA; Boellaard R
    J Nucl Med; 2009 Nov; 50(11):1828-36. PubMed ID: 19837762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An automatic delineation method for bone marrow absorbed dose estimation in (89)Zr PET/CT studies.
    Makris NE; Boellaard R; Menke CW; Lammertsma AA; Huisman MC
    EJNMMI Phys; 2016 Dec; 3(1):13. PubMed ID: 27447823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodistribution, radiation dosimetry and scouting of 90Y-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin's lymphoma using 89Zr-ibritumomab tiuxetan and PET.
    Rizvi SN; Visser OJ; Vosjan MJ; van Lingen A; Hoekstra OS; Zijlstra JM; Huijgens PC; van Dongen GA; Lubberink M
    Eur J Nucl Med Mol Imaging; 2012 Mar; 39(3):512-20. PubMed ID: 22218876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interobserver reproducibility of tumor uptake quantification with
    Jauw YWS; Bensch F; Brouwers AH; Hoekstra OS; Zijlstra JM; Pieplenbosch S; Schröder CP; Zweegman S; van Dongen GAMS; Menke-van der Houven van Oordt CW; de Vries EGE; de Vet HCW; Boellaard R; Huisman MC
    Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1840-1849. PubMed ID: 31209514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodistribution and estimation of radiation-absorbed doses in humans for 13N-ammonia PET.
    Yi C; Yu D; Shi X; He Q; Zhang X; Zhang X
    Ann Nucl Med; 2015 Nov; 29(9):810-5. PubMed ID: 26243501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noise-Induced Variability of Immuno-PET with Zirconium-89-Labeled Antibodies: an Analysis Based on Count-Reduced Clinical Images.
    Jauw YWS; Heijtel DF; Zijlstra JM; Hoekstra OS; de Vet HCW; Vugts DJ; Verheul HM; Boellaard R; Zweegman S; van Dongen GAMS; der Houven van Oordt CWM; Lammertsma AA; Huisman MC
    Mol Imaging Biol; 2018 Dec; 20(6):1025-1034. PubMed ID: 29713958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation dosimetry and biodistribution of the translocator protein radiotracer [(11)C]DAA1106 determined with PET/CT in healthy human volunteers.
    Brody AL; Okita K; Shieh J; Liang L; Hubert R; Mamoun M; Farahi J; Mandelkern MA
    Nucl Med Biol; 2014; 41(10):871-5. PubMed ID: 25156039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetry of 64Cu-DOTA-AE105, a PET tracer for uPAR imaging.
    Persson M; El Ali HH; Binderup T; Pfeifer A; Madsen J; Rasmussen P; Kjaer A
    Nucl Med Biol; 2014 Mar; 41(3):290-5. PubMed ID: 24533988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (S)-4-(3-18F-fluoropropyl)-L-glutamic acid: an 18F-labeled tumor-specific probe for PET/CT imaging--dosimetry.
    Smolarz K; Krause BJ; Graner FP; Wagner FM; Hultsch C; Bacher-Stier C; Sparks RB; Ramsay S; Fels LM; Dinkelborg LM; Schwaiger M
    J Nucl Med; 2013 Jun; 54(6):861-6. PubMed ID: 23568366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved accuracy of the biodistribution and internal radiation dosimetry of
    Yu X; Sun H; Xu L; Han Y; Wang C; Li L; Ng YL; Shi F; Qiu J; Huang G; Zhou Y; Chen Y; Liu J
    Med Phys; 2023 Sep; 50(9):5865-5874. PubMed ID: 37177847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-Step renal dosimetry dependent on cortex geometry applied to 90Y peptide receptor radiotherapy: evaluation using a fillable kidney phantom imaged by 90Y PET.
    Walrand S; Jamar F; van Elmbt L; Lhommel R; Bekonde EB; Pauwels S
    J Nucl Med; 2010 Dec; 51(12):1969-73. PubMed ID: 21078802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of sequential SPECT and CT for targeted radionuclide therapy dosimetry.
    Li T; Wu NY; Song N; Mok GSP
    Ann Nucl Med; 2018 Jan; 32(1):34-43. PubMed ID: 29143283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phantom validation of coregistration of PET and CT for image-guided radiotherapy.
    Lavely WC; Scarfone C; Cevikalp H; Li R; Byrne DW; Cmelak AJ; Dawant B; Price RR; Hallahan DE; Fitzpatrick JM
    Med Phys; 2004 May; 31(5):1083-92. PubMed ID: 15191296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 89Zr-cetuximab PET imaging in patients with advanced colorectal cancer.
    Menke-van der Houven van Oordt CW; Gootjes EC; Huisman MC; Vugts DJ; Roth C; Luik AM; Mulder ER; Schuit RC; Boellaard R; Hoekstra OS; van Dongen GA; Verheul HM
    Oncotarget; 2015 Oct; 6(30):30384-93. PubMed ID: 26309164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter harmonization of 89Zr PET/CT performance.
    Makris NE; Boellaard R; Visser EP; de Jong JR; Vanderlinden B; Wierts R; van der Veen BJ; Greuter HJ; Vugts DJ; van Dongen GA; Lammertsma AA; Huisman MC
    J Nucl Med; 2014 Feb; 55(2):264-7. PubMed ID: 24357686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-in-Human Human Epidermal Growth Factor Receptor 2-Targeted Imaging Using
    Ulaner GA; Lyashchenko SK; Riedl C; Ruan S; Zanzonico PB; Lake D; Jhaveri K; Zeglis B; Lewis JS; O'Donoghue JA
    J Nucl Med; 2018 Jun; 59(6):900-906. PubMed ID: 29146695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation Dosimetry of a Novel Adenosine A
    Zhou X; Elsinga PH; Khanapur S; Dierckx RA; de Vries EF; de Jong JR
    Mol Imaging Biol; 2017 Apr; 19(2):289-297. PubMed ID: 27539309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial assessment of FDG-PET FDG uptake and functional volume during radiotherapy (RT) in patients with non-small cell lung cancer (NSCLC).
    Edet-Sanson A; Dubray B; Doyeux K; Back A; Hapdey S; Modzelewski R; Bohn P; Gardin I; Vera P
    Radiother Oncol; 2012 Feb; 102(2):251-7. PubMed ID: 21885145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.